Research

UC-II Data Shows Joint-Health Benefits For Dogs

A new study presented at the Society of Toxicology’s 48th Annual Meeting & ToxExpo, demonstrates that 40 mg a day of UC-II, from InterHealth Nutraceuticals, helps promote joint comfort and mobility in dogs.

This placebo-controlled study used Kistler Instruments Ground Force Plate, a benchmark for the objective quantitative assessment of joint pain and discomfort in dogs. Ground force plate analysis is determined by measuring peak force and impulse area. Peak force measures the amount of weight the dog is bearing on a given limb and impulse area measures the amount of force applied by the limb onto the plate.

According to study results, UC-II significantly increased peak force by 18% and impulse area by 44% after 120 days, suggesting a significant increase in joint comfort and mobility. In addition, subjective parameters measured after limb manipulation and exercise also demonstrated a significant increase in joint comfort. For further information: www.interhealthusa.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters